From the editors' desk: Why NCATS should read this issue of jgim

摘要

The CTSA program stands at a crossroads as it transitions to NCATS. According to NIH Director Francis Collins, "The mission of NCATS is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of diseases and conditions." NIH has requested public comment on current NCATS priorities for CTSAs. One issue of concern to many is that the full spectrum of translational research continue to receive due attention.